Reading Your Celiac Blood Panel, Marker by Marker

What is on a celiac blood panel?

The panel leads with a pair. The American College of Gastroenterology's preferred first-line test for celiac disease is tissue transglutaminase IgA — tTG-IgA — ordered together with total IgA 1Ref 1Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, Lebwohl B (2023).American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease.That tissue transglutaminase IgA (tTG-IgA) together with total IgA is the preferred first-line celiac test, that testing must be performed while the patient is on a gluten-containing diet, and that duodenal biopsy confirms the diagnosis in most adults.. Those two are not alternatives and they are not redundant. One looks for the antibody that celiac disease produces. The other checks whether your immune system can produce that class of antibody at all.

tTG-IgA — tissue transglutaminase IgA. An antibody test: it looks for an immune response, not for gluten, and not for damage.

Before any single line makes sense, the shape of the process has to be clear, because the numbers only mean something in relation to it. Celiac disease is diagnosed with blood antibody tests followed by a small-intestine biopsy 2Ref 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2020).Diagnosis of Celiac Disease.That celiac disease is diagnosed by blood antibody tests followed by a small-intestine biopsy, and that a person must be eating gluten for those tests to be accurate.. Two steps, in that order. The blood is step one, and step one's job is to decide whether step two happens.

That is a smaller job than people expect the panel to be doing. Most readers arrive at a celiac report hoping for a gluten meter — a number that says how much harm gluten is doing, or how sensitive they are, or how much they can get away with. The panel does none of that. It reports whether your immune system has been making a specific antibody. That is a proxy for the disease, and proxies come with conditions attached. Most of this page is those conditions.

Your own report may carry more lines than these two. What appears on a panel varies, and this page deals with the pair the guideline names first, because that pair is where interpretation actually begins and where it most often goes wrong.

What tTG-IgA is actually measuring

tTG-IgA measures an antibody directed against tissue transglutaminase, an enzyme found in your own tissue. The test looks for that antibody in your blood and reports how much is there. So the number is a record of an immune response — not a measurement of gluten in your body, not a measurement of intestinal damage, and not a measurement of how unwell you feel.

The deepest thing on your report is not a number at all. It is a condition the guideline attaches to the whole test: the testing has to be done while you are eating a gluten-containing diet 1Ref 1Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, Lebwohl B (2023).American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease.That tissue transglutaminase IgA (tTG-IgA) together with total IgA is the preferred first-line celiac test, that testing must be performed while the patient is on a gluten-containing diet, and that duodenal biopsy confirms the diagnosis in most adults.. Sit with that requirement for a second, because it tells you what the test is, more clearly than any definition could.

The panel measures a response to an exposure. Remove the exposure and the response fades — which is why the diet you were on decides whether your result means anything.

A test that only works when you have been eating gluten is, necessarily, a test of a reaction to gluten rather than a test of your underlying biology. It is not reading your genes. It is not reading your intestine directly. It is catching your immune system in the act, which means your immune system has to be in the act when the blood is drawn.

Why an autoimmune reaction to a food protein ends up producing an antibody against one of your own enzymes is a genuinely interesting question, and celiac disease pathophysiology has its own page. For reading your report, the operational fact is enough: no exposure, no response, no matter what is happening in your small intestine.

Why total IgA is on the panel with it

Because tTG-IgA is an IgA test, and not everyone makes normal amounts of IgA. IgA is a class of antibody. If your body produces very little of it, a test that hunts for an IgA-type antibody has nothing available to find, and it will come back negative whether or not you have celiac disease. Total IgA is the control that catches exactly this.

This is why the guideline names a pairing rather than a single test 1Ref 1Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, Lebwohl B (2023).American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease.That tissue transglutaminase IgA (tTG-IgA) together with total IgA is the preferred first-line celiac test, that testing must be performed while the patient is on a gluten-containing diet, and that duodenal biopsy confirms the diagnosis in most adults.. The second number is not extra information about celiac disease. It is information about whether the first number can be believed. It checks the instrument, not you.

Which means a celiac panel reads three ways, not two:

• tTG-IgA positive, total IgA normal. The antibody is there, and the test was capable of finding it. This result carries its full weight.
• tTG-IgA negative, total IgA normal. The antibody was not found, and the test was capable of finding it. This negative carries weight too.
• tTG-IgA negative, total IgA low. The test could not have found the antibody either way.

A negative tTG-IgA sitting next to a low total IgA is not a negative result. It is a blank one.

That third row is the reason the pairing exists, and it is the row people misread, because it looks identical to the second one if you only glance at the tTG-IgA line and see the word negative.

What happens next when total IgA comes back low is a clinical decision, and the alternative routes available are beyond what this page can responsibly source. The part that survives is smaller and still worth having: if your total IgA was low, the tTG-IgA result on your report is not the answer you think you are reading, and that is a specific question to put to whoever ordered it.

The result that means nothing: the gluten problem

This is the most common reason a celiac panel cannot be interpreted, and it is almost always well-intentioned. The testing has to happen while gluten is still being eaten. The ACG guideline requires it 1Ref 1Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, Lebwohl B (2023).American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease.That tissue transglutaminase IgA (tTG-IgA) together with total IgA is the preferred first-line celiac test, that testing must be performed while the patient is on a gluten-containing diet, and that duodenal biopsy confirms the diagnosis in most adults.. NIDDK states that a person must be eating gluten for the tests to be accurate 2Ref 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2020).Diagnosis of Celiac Disease.That celiac disease is diagnosed by blood antibody tests followed by a small-intestine biopsy, and that a person must be eating gluten for those tests to be accurate., and states separately that testing should come before starting a gluten-free diet, because avoiding gluten beforehand can make the results inaccurate 3Ref 3National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2020).Eating, Diet, & Nutrition for Celiac Disease.That celiac testing should occur before starting a gluten-free diet because avoiding gluten beforehand can make results inaccurate, and that a gluten-free diet is the treatment for celiac disease.. Three sources, one rule.

The order is the whole thing: test first, then change the diet. A panel drawn after the diet changed cannot answer the question it was asked.

The sequence that produces the problem is not carelessness. It is initiative. Someone feels terrible for months. They read about gluten. They cut it out. They feel better — genuinely better — and they arrive at an appointment carrying what they reasonably believe is evidence: I think it's gluten, I stopped, and I improved. Blood gets drawn. The panel comes back negative.

And that negative means nothing, because the test measures a response to an exposure that had been removed weeks before the needle went in.

The damage is in what happens to that result afterwards. It gets filed as an answer. The person is told they do not have celiac disease. They stay gluten-free anyway, because it helps. And a question with real consequences — whether they have a lifelong autoimmune condition, whether their children share a genetic risk, whether they need ongoing monitoring — is now closed, with the wrong answer, on the strength of a test that was never in a position to answer it.

Reopening it means going back onto gluten deliberately, for long enough that the immune response returns. That is a gluten challenge, it is nobody's idea of a good few weeks, and it has its own page. Which is the entire argument for the rule about gluten before celiac testing being the first thing anyone hears, rather than something discovered afterwards.

What a positive tTG-IgA means, and what it does not

A positive tTG-IgA means the antibody was found. It does not mean you have celiac disease, because the blood test is not the diagnosis. The ACG guideline holds that duodenal biopsy confirms the diagnosis in most adults 1Ref 1Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, Lebwohl B (2023).American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease.That tissue transglutaminase IgA (tTG-IgA) together with total IgA is the preferred first-line celiac test, that testing must be performed while the patient is on a gluten-containing diet, and that duodenal biopsy confirms the diagnosis in most adults., and NIDDK describes the same two-step sequence: blood antibody tests, then a small-intestine biopsy 2Ref 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2020).Diagnosis of Celiac Disease.That celiac disease is diagnosed by blood antibody tests followed by a small-intestine biopsy, and that a person must be eating gluten for those tests to be accurate.. What a positive panel earns you is the second step.

There is a principle underneath that, and it is worth stating because it explains why medicine is not satisfied by your number alone. Grading the evidence for a diagnostic test means weighing the downstream consequences of testing — the true positives, the false positives, the true and false negatives — because a test only improves outcomes through the decisions it changes 4Ref 4Schünemann HJ, Oxman AD, Brozek J, et al. (2008).Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.The principle that a diagnostic test's value rests on the downstream patient-important consequences of testing rather than on accuracy alone, because a test improves outcomes only through the management decisions it changes.. Applied here: the tTG-IgA's job is not to be right about your intestine. Its job is to decide correctly who gets a biopsy. It is measured against that, and only that.

And then, immediately after a positive result, comes the trap — the exact mirror of the one in the section above, and it catches people who are doing their level best.

The panel comes back positive. It reads like a diagnosis. The obvious, responsible-feeling response is to stop eating gluten that day. But the biopsy has not happened yet, and the same rule that governed the blood governs the tissue: the tests are accurate only while gluten is being eaten 2Ref 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2020).Diagnosis of Celiac Disease.That celiac disease is diagnosed by blood antibody tests followed by a small-intestine biopsy, and that a person must be eating gluten for those tests to be accurate.. Going gluten-free in the gap between a positive blood test and the duodenal biopsy can undo the second step before it takes place, and leave you exactly where the previous section's reader ended up — living the diet, without the diagnosis.

So a positive result is not the finish line, and it is not permission to start. It is a referral.

What a negative result means, and what it does not

A negative tTG-IgA is meaningful when three things are true at once: the result is negative, the total IgA on the same panel was normal, and you were eating gluten when the blood was drawn. All three conditions carry weight. A low total IgA makes the negative uninformative, and a gluten-free diet beforehand makes it uninterpretable 1Ref 1Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, Lebwohl B (2023).American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease.That tissue transglutaminase IgA (tTG-IgA) together with total IgA is the preferred first-line celiac test, that testing must be performed while the patient is on a gluten-containing diet, and that duodenal biopsy confirms the diagnosis in most adults.3Ref 3National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2020).Eating, Diet, & Nutrition for Celiac Disease.That celiac testing should occur before starting a gluten-free diet because avoiding gluten beforehand can make results inaccurate, and that a gluten-free diet is the treatment for celiac disease.. A negative that satisfies all three is worth something real.

Here is what it is not worth. A negative celiac panel does not explain your symptoms, and it does not make them harmless. "Not celiac" is not a diagnosis. It is the removal of one item from a list, and the list is what matters.

Because of what else is on it. NIDDK names symptoms that call for prompt medical evaluation rather than continued self-management: rectal bleeding, blood in the stool, constant abdominal pain, an inability to pass gas, vomiting, unintentional weight loss, and a family history of colorectal cancer 5Ref 5National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2018).Symptoms & Causes of Constipation.The enumeration of symptoms warranting prompt medical evaluation: rectal bleeding, blood in stool, constant abdominal pain, inability to pass gas, vomiting, unintentional weight loss, and family history of colorectal cancer.. A negative celiac result does not touch a single one of those. It was not looking for any of them. If one of them is part of your picture, it needs its own evaluation on its own timeline, and a clean celiac panel is not a reason to put that off.

That point is worth being blunt about, because a negative test is a powerful thing psychologically. It arrives looking like an all-clear. It feels like being sent home. And a result that rules out one autoimmune condition tells you nothing whatsoever about bleeding, weight loss, or pain that will not settle.

For the many people who have real symptoms, a properly negative panel, and no answer yet: the question is still open, not closed. Whether what you have is non-celiac gluten sensitivity, something else, or more than one thing at once is not something this test was built to determine. The gluten sensitivity vs celiac distinction has its own page, as does the ibs versus celiac question, and both are better places to go next than a second reading of the same report.

What the panel actually decides

A test earns its place through the decisions it changes, not through its accuracy in the abstract 4Ref 4Schünemann HJ, Oxman AD, Brozek J, et al. (2008).Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.The principle that a diagnostic test's value rests on the downstream patient-important consequences of testing rather than on accuracy alone, because a test improves outcomes only through the management decisions it changes.. So the useful question about your celiac panel is not whether the number is high. It is: what does this number move? The answer is short, and narrower than most people assume. It decides whether a biopsy happens. On its own, almost nothing else on the report decides anything at all.

That framing matters because of the size of what waits at the other end. The treatment for celiac disease is a gluten-free diet 3Ref 3National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2020).Eating, Diet, & Nutrition for Celiac Disease.That celiac testing should occur before starting a gluten-free diet because avoiding gluten beforehand can make results inaccurate, and that a gluten-free diet is the treatment for celiac disease.. Not a course of something that gets finished, but a permanent rearrangement of eating — of travel, of family meals, of every restaurant, of reading every label, for the rest of a life. A commitment on that scale deserves a confirmed diagnosis rather than a probable one. That is what the second step is for, and it is why the system does not simply take the blood test's word for it.

Which cuts in both directions, and this is the whole point:

• Going gluten-free on a positive blood test alone means taking on the diet without the confirmation — and simultaneously destroying your ability to obtain it.
• Going gluten-free on a negative blood test that was drawn after you had already gone gluten-free means taking on the diet on the basis of no information whatsoever.

Both roads arrive at the same address: a person living a gluten-free life who does not know whether they have an autoimmune disease. That is precisely the outcome the two-step sequence is built to prevent, and it is why the order of operations gets more emphasis on this page than any individual number does.

The panel's whole job is to decide whether a biopsy happens. It was never built to decide what you eat.

If you take one thing from your report, let it be the question it answers rather than the flag in the margin. The flag is the lab talking to your clinician. The question is yours.